Viral Oncoproteins Discriminate between p53 and the p53 Homolog p73

REFERENCES

• Band, V., S. Dalal, L. Delmolino, and E. J. Androphy 1993. Enhanced degradation of p53 protein in HPV-E6 and BPV-1 E6 immortalized human mammary epithelial cells. EMBO J. 12: 1847–1852.
   PubMed Web of Science ®Google Scholar
• Bargonetti, J., J. J. Manfredi, X. Chen, D. R. Marshak, and C. Prives 1993. A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not oncogenic mutant p53 protein. Genes Dev. 7: 2565–2574.
   PubMed Web of Science ®Google Scholar
• Bargonetti, J., I. Reynisdottir, P. N. Friedman, and C. Prives 1992. Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53. Genes Dev. 6: 1886–1898.
   PubMed Web of Science ®Google Scholar
• Braithwaite, A. W., G. E. Blair, C. C. Nelson, J. McGovern, and A. J. Bellett 1991. Adenovirus E1b-58 kD antigen binds to p53 during infection of rodent cells: evidence for an N-terminal binding site on p53. Oncogene 6: 781–787.
   PubMedGoogle Scholar
• Caput, D. Unpublished data.
   Google Scholar
• Cheng, N. C., N. Van Roy, A. Chan, M. Beitsma, A. Westerveld, F. Speleman, and R. Versteeg 1995. Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p36 region, only one of which is associated with N-myc amplification. Oncogene 10: 291–297.
   PubMed Web of Science ®Google Scholar
• Chiba, I., T. Takahashi, M. M. Nau, D. D. D’Amico, D. T. Curiel, T. Mitsudomi, D. L. Buchhagen, D. Carbone, S. Piantadosi, H. Koga, P. T. Reissman, D. J. Slamon, E. C. Holmes, and J. D. Minna 1990. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Oncogene 5: 1603–1610.
   PubMed Web of Science ®Google Scholar
• Cho, Y., S. Gorina, P. D. Jeffrey, and N. P. Pavletich 1994. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265: 346–55.
   PubMed Web of Science ®Google Scholar
• Debbas, M., and E. White 1993. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 7: 546–554.
   PubMed Web of Science ®Google Scholar
• Diller, L., J. Kassel, C. Nelson, M. Gryka, G. Litwak, M. Gebhardt, B. Bressac, M. Ozturk, S. Baker, B. Vogelstein, and S. Friend 1990. p53 functions as a cell cycle control protein in osteosarcoma. Mol. Cell. Biol. 10: 5772–5781.
   PubMed Web of Science ®Google Scholar
• El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817–825.
   PubMed Web of Science ®Google Scholar
• Farmer, G., J. Bargonetti, H. Zhu, P. Fridman, R. Prywes, and C. Prives 1992. Wild-type p53 activates transcription in vitro. Nature 358: 83–86.
   PubMed Web of Science ®Google Scholar
• Graham, F. L., and A. van der Eb 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. J. Virol. 52: 456–467.
   Web of Science ®Google Scholar
• Harlow, E., L. V. Crawford, D. C. Pim, and N. M. Williamson 1981. Monoclonal antibodies specific for simian virus 40 tumor antigens. J. Virol. 39: 861–869.
   PubMed Web of Science ®Google Scholar
• Harlow, E., and D. Lane 1988. Antibodies: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
   Google Scholar
• Hollstein, M. K., K. Rice, M. S. Greenblatt, T. Soussi, R. Fucks, T. Sorlie, E. Hovig, B. Smith-Sorenson, R. Montesano, and C. C. Harris 1994. Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res. 22: 3551–3555.
   PubMed Web of Science ®Google Scholar
• Hoppe-Seyler, F., and K. Butz 1993. Repression of endogenous p53 transactivation function in HeLa cervical carcinoma cells by human papillomavirus type 16 E6, human mdm-2, and mutant p53. J. Virol. 67: 3111–3117.
   PubMed Web of Science ®Google Scholar
• Hsieh, J., S. Fredersdorf, T. Kouzarides, K. Martin, and X. Lu 1997. E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev. 11: 1840–1852.
   PubMedGoogle Scholar
• Huibregtse, J. M., M. Scheffner, and P. M. Howley 1991. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO 10: 4129–4135.
   PubMed Web of Science ®Google Scholar
• Jiang, D., A. Srinivasan, G. Lozano, and P. D. Robbins 1993. SV40 T antigen abrogates p53-mediated transcriptional activity. Oncogene 8: 2805–2812.
   PubMed Web of Science ®Google Scholar
• Jost, C., M. Marin, and W. G. Kaelin 1997. p73 is a human p53-related protein that can induce apoptosis. Nature 389: 191–194.
   PubMed Web of Science ®Google Scholar
• Jost, C. A., D. Ginsberg, and W. G. Kaelin 1996. A conserved region of unknown function participates in the recognition of E2F family members by the adenovirus E4 ORF 6/7 protein. Virology 220: 78–90.
   PubMedGoogle Scholar
• Kaghad, M., H. Bonnet, A. Yang, L. Creancier, J.-C. Biscan, A. Valent, A. Minty, P. Chalon, J.-M. Lelias, X. Dumont, P. Ferrara, F. McKeon, and D. Caput 1997. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90: 809–819.
   PubMed Web of Science ®Google Scholar
• Kao, C. C., P. R. Yew, and A. J. Berk 1990. Domains required for in vitro association between the cellular p53 and the adenovirus 2 E1B 55K proteins. Virology 179: 806–814.
   PubMed Web of Science ®Google Scholar
• Kierstead, T. D., and M. J. Tevethia 1993. Association of p53 binding and immortalization of primary C57BL/6 mouse embryo fibroblasts by using simian virus 40 T-antigen mutants bearing internal overlapping deletion mutations. J. Virol. 67: 1817–1829.
   PubMedGoogle Scholar
• Kowalik, T., J. DeGregori, J. Schwarz, and J. Nevins 1995. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J. Virol. 69: 2491–2500.
   PubMedGoogle Scholar
• Lane, D. P., and L. V. Crawford 1979. T antigen is bound to a host protein in SV40-transformed cells. Nature 278: 261–263.
   PubMed Web of Science ®Google Scholar
• Li, B., and S. Fields 1993. Identification of mutations in p53 that affect its binding to SV40 large T antigen by using the yeast two-hybrid system. FASEB J. 7: 957–963.
   PubMed Web of Science ®Google Scholar
• Li, X., and P. Coffino 1996. High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation. J. Virol. 70: 4509–4516.
   PubMed Web of Science ®Google Scholar
• Lin, J., J. Chen, B. Elenbaas, and A. J. Levine 1994. Several hydrophobic amino-acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes Dev. 8: 1235–1246.
   PubMed Web of Science ®Google Scholar
• Linzer, D. I. H., and A. J. Levine 1979. Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 17: 43–52.
   PubMed Web of Science ®Google Scholar
• Mansur, C. P., B. Marcus, S. Dalal, and E. J. Androphy 1995. The domain of p53 required for binding HPV 16 E6 is separable from the degradation domain. Oncogene 10: 457–465.
   PubMedGoogle Scholar
• Mietz, J. A., T. Unger, J. M. Huibregtse, and P. M. Howley 1992. The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein. EMBO 11: 5013–5020.
   PubMed Web of Science ®Google Scholar
• Osada, M., M. Ohba, C. Kawahara, C. Ishioka, R. Kanamaru, I. Katoh, Y. Ikawa, Y. Nimura, A. Nakagawara, M. Obinata, and S. Ikawa 1998. Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nat. Med. 4: 839–843.
   PubMed Web of Science ®Google Scholar
• Pavletich, N. P., K. A. Chambers, and C. O. Pabo 1993. The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots. Genes Dev. 7: 2556–2564.
   PubMed Web of Science ®Google Scholar
• Phillips, A., S. Bates, K. Ryan, K. Helin, and K. Vousden 1997. Induction of DNA synthesis and apoptosis are separable functions of E2F-1. Genes Dev. 11: 1853–1863.
   PubMedGoogle Scholar
• Polyak, K., Y. Xia, J. Zweier, K. Kinzler, and B. Vogelstein 1997. A model for p53-induced apoptosis. Nature 389: 300–305.
   PubMed Web of Science ®Google Scholar
• Qin, X. Q., D. M. Livingston, W. G. Kaelin, and P. Adams 1994. Deregulated E2F1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA 91: 10918–10922.
   PubMed Web of Science ®Google Scholar
• Ruppert, J., and B. Stillman 1993. Analysis of a protein-binding domain of p53. Mol. Cell. Biol. 13: 3811–3820.
   PubMedGoogle Scholar
• Scheffner, M., T. Takahashi, J. Huibregtse, J. Minna, and P. Howley 1992. Interaction of the human papillomavirus type 16 E6 oncoprotein with wild-type and mutant human p53 proteins. J. Virol. 66: 5100–5105.
   PubMed Web of Science ®Google Scholar
• Scheffner, M., B. A. Werness, J. M. Huibregtse, A. J. Levine, and P. M. Howley 1990. The E6 oncoprotein encoded by human papillomaviruses types 16 and 18 promotes the degradation of p53. Cell 63: 1129–1136.
   PubMed Web of Science ®Google Scholar
• Schmale, H., and C. Bamberger 1997. A novel protein with strong homology to the tumor suppressor p53. Oncogene 15: 1363–1367.
   PubMed Web of Science ®Google Scholar
• Segawa, K., A. Minowa, K. Sugaswa, T. Takano, and F. Hanaoka 1993. Abrogation of p53-mediated transactivation by SV40 large T antigen. Oncogene 8: 543–548.
   PubMed Web of Science ®Google Scholar
• Shan, B., and W.-H. Lee 1994. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol. 14: 8166–8173.
   PubMedGoogle Scholar
• Sturzbecher, H. W., T. Maimets, P. Chumakov, R. Brain, C. Addison, V. Simanis, K. Rudge, R. Philp, M. Grimaldi, W. Court, and J. R. Jenkins 1990. p53 interacts with p34 cdc2 in mammalian cells: implication for cell cycle control and oncogenesis. Oncogene 5: 795–801.
   PubMedGoogle Scholar
• Takeda, O., C. Homma, N. Maseki, M. Sakurai, N. Kanda, M. Schwab, Y. Nakamura, and Y. Kaneko 1994. There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma. Genes Chrom. Cancer 10: 30–39.
   PubMedGoogle Scholar
• Trink, B., K. Okami, L. Wu, V. Sriuranpong, J. Jen, and D. Sidransky 1998. A new human p53 homologue. Nat. Med. 4: 747.
   PubMed Web of Science ®Google Scholar
• Versteeg, R., H. Caron, N. C. Cheng, P. van der Drift, R. Slater, A. Westerveld, P. A. Voute, O. Delattre, G. Laureys, N. Van Roy, and F. Speleman 1995. 1p36: every subband a suppressor. Eur. J. Cancer 31A: 538–541.
   PubMedGoogle Scholar
• Wang, Y., M. Reed, P. Wang, J. E. Stenger, G. Mayr, M. E. Anderson, J. F. Schwedes, and P. Tegtmeyer 1993. p53 domains: identification and characterization of two autonomous DNA-binding regions. Genes Dev. 7: 2575–2586.
   PubMedGoogle Scholar
• Werness, B. A., A. J. Levine, and P. M. Howley 1990. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248: 76–79.
   PubMed Web of Science ®Google Scholar
• Wu, X., and A. J. Levine 1994. p53 and E2F1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA 91: 3602–3606.
   PubMed Web of Science ®Google Scholar
• Yew, P. R., and A. J. Berk 1992. Inhibition of p53 transactivation required for transformation by adenovirus early E1B protein. Nature 357: 82–85.
   PubMed Web of Science ®Google Scholar
• Zalvide, J., and J. A. DeCaprio 1995. Role of pRB-related proteins in simian virus 40 large T-antigen-mediated transformation. Mol. Cell. Biol. 15: 5800–5810.
   PubMedGoogle Scholar